{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:40:57Z","timestamp":1787755257740,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JBJS Case Connector"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n                    <jats:title>Case:<\/jats:title>\n                    <jats:p>We report the case of a 50-year-old woman with oncogenic osteomalacia secondary to a metastatic phosphaturic mesenchymal tumor (PMT) that presented, to our knowledge, with the first reported lesion in the talus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Oncogenic osteomalacia is a rare condition with a unique serum biochemical profile that requires a high index of suspicion for diagnosis. A PMT is a rare neoplasm that can lead to oncogenic osteomalacia through secretion of fibroblast growth factor 23. Symptoms can be debilitating, and diagnostic delays are extremely common. This case report emphasizes the importance of comprehensive anatomic assessment and the need for fastidious postoperative monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2106\/jbjs.cc.16.00172","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T20:55:27Z","timestamp":1498683327000},"page":"e40-e40","source":"Crossref","is-referenced-by-count":10,"title":["Oncogenic Osteomalacia Secondary to a Metastatic Phosphaturic Mesenchymal Tumor in the Talus"],"prefix":"10.2106","volume":"7","author":[{"given":"Keith T.","family":"Aziz","sequence":"first","affiliation":[{"name":"Departments of Orthopaedic Surgery (K.T.A.) and Pathology (E.F.M), and the Division of Orthopaedic Oncology (C.D.M.), The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward F.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Departments of Orthopaedic Surgery (K.T.A.) and Pathology (E.F.M), and the Division of Orthopaedic Oncology (C.D.M.), The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol D.","family":"Morris","sequence":"additional","affiliation":[{"name":"Departments of Orthopaedic Surgery (K.T.A.) and Pathology (E.F.M), and the Division of Orthopaedic Oncology (C.D.M.), The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,6,28]]},"reference":[{"issue":"1","key":"bib1-20230712","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol."},{"issue":"9308","key":"bib2-20230712","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","article-title":"Localisation of mesenchymal tumours by somatostatin receptor imaging","volume":"359","author":"Jan de Beur","year":"2002","journal-title":"Lancet."},{"issue":"13","key":"bib3-20230712","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.N.01299","article-title":"Surgical treatments of tumor-induced osteomalacia lesions in long bones: seventeen cases with more than one year of follow-up","volume":"97","author":"Wang","year":"2015","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib4-20230712","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","article-title":"Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia","volume":"91","author":"Imel","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"bib5-20230712","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","article-title":"A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery","volume":"40","author":"Elston","year":"2007","journal-title":"Bone."},{"key":"bib6-20230712","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12891-015-0496-3","article-title":"Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors","volume":"16","author":"Sun","year":"2015","journal-title":"BMC Musculoskelet Disord."},{"issue":"11","key":"bib7-20230712","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s11999-013-3178-1","article-title":"The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?","volume":"471","author":"Ledford","year":"2013","journal-title":"Clin Orthop Relat Res."},{"issue":"9","key":"bib8-20230712","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res."},{"key":"bib9-20230712","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","article-title":"68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT","volume":"64","author":"Breer","year":"2014","journal-title":"Bone."},{"issue":"11","key":"bib10-20230712","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/modpathol.2016.137","article-title":"Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors","volume":"29","author":"Lee","year":"2016","journal-title":"Mod Pathol."},{"key":"bib11-20230712","first-page":"150025","article-title":"Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors","volume":"2015","author":"Yavropoulou","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"bib12-20230712","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00003086-197011000-00003","article-title":"Pathology of metastatic tumors in bone","volume":"73","author":"Johnston","year":"1970","journal-title":"Clin Orthop Relat Res."},{"issue":"5","key":"bib13-20230712","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF00350965","article-title":"Metastatic tumours of bones of the hand and foot. A comparative review and report of 43 additional cases","volume":"16","author":"Libson","year":"1987","journal-title":"Skeletal Radiol."},{"issue":"5","key":"bib14-20230712","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2106\/00004623-198668050-00017","article-title":"Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet","volume":"68","author":"Healey","year":"1986","journal-title":"J Bone Joint Surg Am."},{"issue":"7","key":"bib15-20230712","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3113\/FAI.2008.0699","article-title":"Metastatic skeletal disease of the foot: case reports and literature review","volume":"29","author":"Maheshwari","year":"2008","journal-title":"Foot Ankle Int."},{"issue":"6","key":"bib16-20230712","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"26","key":"bib17-20230712","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","article-title":"Octreotide therapy for tumor-induced osteomalacia","volume":"345","author":"Seufert","year":"2001","journal-title":"N Engl J Med."},{"issue":"4","key":"bib18-20230712","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest."},{"issue":"11","key":"bib19-20230712","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"11","key":"bib20-20230712","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.humpath.2013.04.027","article-title":"Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis","volume":"44","author":"Uchihashi","year":"2013","journal-title":"Hum Pathol."}],"container-title":["JBJS Case Connector"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01709767-201707020-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:40:15Z","timestamp":1787751615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01709767-201707020-00019"}},"subtitle":["A Case Report and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.cc.16.00172","relation":{},"ISSN":["2160-3251"],"issn-type":[{"value":"2160-3251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}